Skip to main content
Decorative image of the AMR Learning Lounge

Transforming Diagnostics in GI Infections: The Role of Molecular Testing

SUMMARY

Medical Laboratory Observer | October 2024

Gain valuable insights into the pressing challenge of diagnosing gastrointestinal infections (GI) in the context of antimicrobial resistance (AMR). In this exclusive article, David Allen, PharmD, BCIDP, examines how innovative molecular diagnostics are transforming clinical practices, enabling faster and more accurate identification of pathogens. Dr. Allen addresses the significant benefits these advancements bring to patient outcomes and antimicrobial stewardship (AMS) efforts, helping healthcare professionals stay informed on the latest developments in this critical area.

 

FEATURED EXPERTS 

David Allen, PharmD, BCIDP, Field Medical Director, bioMérieux

 


GET STARTED

Discover how molecular diagnostics are improving the management of gastrointestinal infections.

 


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


YOU MAY ALSO LIKE

Join Stephen Vella, PhD, Medical Science Liaison at bioMérieux and Jillian Cotter, MD, Assistant Professor at Children's Hospital Colorado, as they discuss Diagnosing and Treating GI Infections with an Antimicrobial Stewardship Perspective.

GLOBAL STEWARDSHIP SOLUTIONS

Learn how bioMérieux's diagnostic solutions can address your GI-related challenges and help elevate your stewardship efforts.

PUBLISHED BY

January 08, 2025


SHARE THIS ARTICLE: